May 5th 2021, 4:00pm
In a minority-predominant patient population, a standardized pathway for total knee arthroplasty was associated with improved outcomes with no change in postoperative complication rates.
March 10th 2021, 5:00pm
Fracture prediction tools for East Asian individuals vary by country. In the United States, the US-Asian Fracture Risk Assessment Tool provides hip fracture probabilities that correspond to observed estimates.
December 11th 2020, 2:00pm
The economic burden of osteoporotic fractures may be much higher than estimated: just the tip of the iceberg. In this letter, we suggest that the cost of these fractures might be underestimated by considering only direct medical cost.
May 8th 2020, 5:00pm
Osteoporotic fractures are associated with a significant economic burden, including costs of rehabilitation services and a high total all-cause cost of care.
March 5th 2020, 10:00pm
This study provides proof of concept that imminent risk of fracture can be assessed by evaluating recent fracture, age, sex, race, medically significant falls, and psychoactive medications.
June 27th 2019, 4:54pm
Giving infants proton pump inhibitors alone and together with histamine H2-receptor agonists is associated with an increased risk of childhood fracture.
June 24th 2019, 11:47pm
Postural sway, the tendency to sway even while standing still, is an independent risk factor for bone fractures in postmenopausal women.
June 22nd 2019, 4:00pm
Bone is one of the most frequent sites of metastasis in breast cancer, but the exact reasons for this high risk of bone metastases has not been well understood. However, research has found that physics may be partly the reason for this high risk.
June 19th 2019, 7:17pm
Women 80 years or older with osteoporosis have a high hip fracture probability even when accounting for mortality risk, suggesting that these patients are candidates for drug treatment to prevent hip fractures.
June 15th 2019, 6:00pm
Skeletal-related events are frequent complications in patients with cancers. Two abstracts analyzed the use of bone-modifying agents in patients with newly diagnosed multiple myeloma and breast cancer.
